Influenza A and febrile seizures in childhood.
The aims of the present study are to identify predisposing factors of febrile seizures in influenza A infection and to clarify the special characteristics of febrile seizures in children with influenza A infection. Between January and July 2005, children hospitalized because of febrile seizures and subsequently confirmed influenza A infection were enrolled as subjects. Age-matched control subjects were those admitted as a result of influenza A infection but no febrile seizures (control 1) and children who developed febrile seizures with negative viral studies (control 2). Significant factors for the development of febrile seizures include: history of febrile seizures, family history of seizure disorders, and coexisting gastroenteritis. Independent risk factor for febrile seizures was history of febrile seizures (odds ratio 7.58, 95% confidence interval CI 1.48 to 38.84, P = 0.015). When compared with children who developed febrile seizures with negative virus studies, children who developed febrile seizures in influenza A infection had a significantly higher maximum body temperature, shorter duration of fever before seizure onset, and more frequent occurrence of partial seizures. Current episode represented first seizure in 26.5% of children infected with influenza A as compared with 50% of children whose virus studies were negative (P = 0.04). The findings suggest that effective vaccination may prevent development of febrile seizures, especially in those patients with past history of febrile seizures. Rapid diagnostic testing for influenza infection in the management of complex febrile seizures, especially during influenza season, is cost-effective.
Kwong
Karen L
KL
Department of Pediatrics, Tuen Mun Hospital, Hong Kong. karenkwong@graduate.hku.hk
Lam
Shu Y
SY
Que
Tak L
TL
Wong
Sik N
SN
D002648:Child; D002673:Child, Hospitalized / Q000706:statistics & numerical data; D002675:Child, Preschool; D004828:Epilepsies, Partial / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D005260:Female; D005334:Fever / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D006801:Humans; D007223:Infant; D009980:Influenza A virus; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000150:complications* / Q000453:epidemiology* / Q000517:prevention & control; D008297:Male; D012307:Risk Factors; D003294:Seizures, Febrile / Q000453:epidemiology* / Q000517:prevention & control / Q000821:virology*
D007252:Influenza Vaccines